COVID-19 has now been labelled a pandemic, necessitating the development of novel medicines as we move beyond containment. All eyes are on people working on the front lines of drug development and production. There is tremendous demand to provide both urgent and long-term remedies for people who have been impacted, as well as biotherapies and vaccines to avoid future outbreaks. It is unrealistic to meet the current global crisis by developing new pharmaceuticals from the ground up because it is a lengthy procedure. Drug repurposing screens are a helpful and successful method of identifying prospective SARS-CoV-2 treatments.